Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 USD | +0.62% | +2.55% | +14.18% |
May. 02 | ATyr Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 02 | Earnings Flash (LIFE) ATYR PHARMA Reports Q1 Revenue $235,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.18% | 109M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- LIFE Stock
- News aTyr Pharma, Inc.
- aTyr Pharma : RBC Initiates aTyr Pharma at Outperform, Speculative Risk, Sets Price Target at $22, Says Lead Product is Underappreciated